Cardio Diagnostics Holdings Inc has a consensus price target of $5 based on the ratings of 2 analysts. The high is $8 issued by Northland Capital Markets on May 22, 2023. The low is $2 issued by Benchmark on June 6, 2024. The 3 most-recent analyst ratings were released by Benchmark on June 6, 2024, April 19, 2024, and June 15, 2023, respectively. With an average price target of $3.78 between Benchmark, there's an implied 602.83% upside for Cardio Diagnostics Holdings Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
06/06/2024 | Buy Now | 271.54% | Benchmark | Bruce Jackson | $1.35 → $2 | Maintains | Speculative Buy | Get Alert |
04/19/2024 | Buy Now | 150.79% | Benchmark | Bruce Jackson | $4 → $1.35 | Maintains | Speculative Buy | Get Alert |
06/15/2023 | Buy Now | 1386.16% | Benchmark | Bruce Jackson | → $8 | Reiterates | Speculative Buy → Speculative Buy | Get Alert |
05/22/2023 | Buy Now | 1386.16% | Northland Capital Markets | Carl Byrnes | → $8 | Initiates | → Outperform | Get Alert |
04/18/2023 | Buy Now | 1386.16% | Benchmark | Bruce Jackson | → $8 | Reiterates | → Speculative Buy | Get Alert |
The latest price target for Cardio Diagnostics Hldgs (NASDAQ:CDIO) was reported by Benchmark on June 6, 2024. The analyst firm set a price target for $2.00 expecting CDIO to rise to within 12 months (a possible 277.36% upside). 2 analyst firms have reported ratings in the last year.
The latest analyst rating for Cardio Diagnostics Hldgs (NASDAQ:CDIO) was provided by Benchmark, and Cardio Diagnostics Hldgs maintained their speculative buy rating.
There is no last upgrade for Cardio Diagnostics Hldgs
There is no last downgrade for Cardio Diagnostics Hldgs.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cardio Diagnostics Hldgs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cardio Diagnostics Hldgs was filed on June 6, 2024 so you should expect the next rating to be made available sometime around June 6, 2025.
While ratings are subjective and will change, the latest Cardio Diagnostics Hldgs (CDIO) rating was a maintained with a price target of $1.35 to $2.00. The current price Cardio Diagnostics Hldgs (CDIO) is trading at is $0.53, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.